Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 79012 · Class II · OneBlood, Inc.
Key facts
| Event ID | 79012 |
|---|---|
| Recall numbers | B-0361-2018 |
| Recalling firm | OneBlood, Inc. |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, which did not meet the acceptable product specifications, was distributed. |
| Initiation date | Dec 22, 2017 |
| Report date | Feb 28, 2018 |
| Termination date | Feb 20, 2018 |
| City | Orlando |
| State | FL |
| Country | United States |
| FEI number | 1072425 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: